Search

everythinglearnresearchcommunity

for

Search:↓

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.

Mycophenolate mofetil can effectively treat autoimmune hepatitis when standard drugs fail.

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

New treatments and understanding of skin lupus are emerging in 2024.

Understanding and treating alopecia areata improves patient care.

A woman with Parry-Romberg syndrome developed new curly hair on one side of her scalp, a condition not previously linked to the syndrome.

A woman was injured by a hedgehog falling on her, causing skin lesions but no disease.

Dermoscopy is a useful tool for identifying features of skin conditions, but more research is needed to define its role in dermatology.

Choosing the right patients, using proper techniques, and having thorough knowledge are key to preventing and managing dermal filler complications.

Fullerenes show potential in skin care but need more safety research.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Atopic dermatitis is common in developing countries, but many patients receive poor care due to inconsistent guidelines and lack of resources.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Early onset and pustules indicate severe hair follicle inflammation, and while antibiotics help, the condition often worsens after treatment stops.

High-frequency ultrasonography is a useful but underused tool in dermatology for assessing skin cancers, monitoring diseases, and evaluating treatments.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Both mouse and rat models are effective for testing alopecia areata treatments.

The article explains the genetic causes and symptoms of various hair disorders and highlights the need for more research to find treatments.

Different hair care practices and conditions affect African American hair and scalp health, requiring specialized knowledge for treatment.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Some treatments for folliculitis decalvans work well, with tetracyclines and a mix of rifampicin and clindamycin being most effective.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Some congenital hair disorders improve in childhood or with treatments like minoxidil and retinoids, while others like Netherton syndrome and trichothiodystrophy have a poor prognosis.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

β-blockers can cause skin problems like psoriasis and vitiligo, and doctors should tell patients about these risks.